West Pharma price target raised to $400 from $365
Morgan Stanley raised its price target on West Pharmaceutical Services to $400 from $365, per Benzinga ratings actions.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.